Medical University of South Carolina
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Medical University of South Carolina sits in the top decile of US sponsors by registered trial count (#44 of 15,742 sponsors by registered trial count).
Medical University of South Carolina: 755 sponsored US clinical trials, 142 recruiting.
Medical University of South Carolina sponsors 755 registered US clinical trials on ClinicalTrials.gov, 142 of them currently recruiting, and 520 completed. 66 of these trials are in Phase 3-4 (later-stage) and 228 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 15 trials.
Top-decile sponsor footprint
Medical University of South Carolina ranks in the top decile of sponsors by registered trial count (#44 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
520 of 580 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
755 total, page 3 of 16
RECOVERS - Realigning Emotion and COgnition Via prEcision Regulation networkS
NCT05977439
taVNS-Paired Breastfeeding to Improve Breastfeeding at Discharge
NCT06417385
NAC vs Placebo on Opioid Use for Hysterectomy
NCT06039566
Metabolically Fit CD19 CAR T-cell Therapy With CD34 Selection in Patients With CD19+ Relapsed/Refractory NHL, CLL/SLL
NCT05702853
Reduction of Myopotential Interference With Smart Pass in S-ICD Patients
NCT05766943
SCORE Emerging Adult Cannabis Use & Stress
NCT05885542
Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy
NCT05793151
Impact of Cigarette and E-cigarette Menthol Regulation on Current Smokers of Menthol Cigarettes
NCT05896033
Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT for Long COVID)
NCT05855369
Cold Atmospheric Plasma Device Extension Study
NCT05937672
Operant Conditioning of Spinal Reflexes Training System--Reflex Operant Down Conditioning
NCT05094362
The SNAP Tool for Head and Neck Cancer Survivor-Caregiver Dyads
NCT05811936
EMPOWER: Effects of Weight Loss and Exercise Post-stroke
NCT05901675
Cognitive Decline Following Deep Brain Stimulation
NCT05822388
Neuropathic Pain and Operant Conditioning of Cutaneous Reflexes After SCI
NCT05492188
RM1 Project 1 - tAN Naloxone
NCT05490134
RM1 Project 2 - tAN fMRI
NCT05487664
taVNS or TMS or Both for Depression
NCT05725239
Brief Family Involved Treatment Telehealth
NCT05674409
Investigating Novel Smoking Cessation Primary Care Interventions in Rural Environments
NCT05764759
Building a Renewed ImaGe After Head & Neck Cancer Treatment (BRIGHT) Multi-Site RCT
NCT05442957
CARS: Cannabis and Alcohol Reduction Study
NCT05486234
Testing a Scalable Model of Care to Improve Patients Access to Mental Health Services After Traumatic Injury
NCT05497115
Bayer OA Knee Pain Pilot
NCT05349682
Enhancing Smoking Cessation Via Telehealth Options in Primary Care
NCT05493254
Thoracic Neuromodulation for Diabetic Gastroparesis
NCT05273788
Evaluation of Trauma Center-Based Intervention for Adolescent Traumatic Injury Survivors
NCT05086757
COAST Therapy in Advanced Solid Tumors and Prostate Cancer
NCT05036226
Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders
NCT05064319
Weekly Sirolimus Therapy
NCT04861064
Autologous Mesenchymal Stromal Cells and Islet Co-transplantation in TP-IAT
NCT05095532
Optimizing Tobacco Treatment Delivery for People Living With HIV
NCT05019495
Wrist Extensor MEP Up-conditioning for Individuals With Incomplete Spinal Cord Injury
NCT05321017
MPFC Theta Burst Stimulation as a Treatment Tool for Alcohol Use Disorder: Effects on Drinking and Incentive Salience
NCT04998916
Modulating Anxious Coping
NCT04824105
RTMS Targets Neural Circuits for Smoking Cessation
NCT04903028
Oxytocin to Enhance Integrated Treatment for AUD and PTSD
NCT04523922
Cellular Therapy for Type 1 Diabetes Using Mesenchymal Stem Cells
NCT04061746
Stroke Thrombectomy and Aneurysm Registry
NCT04994756
Accelerated iTBS for Post Partum Depression
NCT03417960
Quantitative Cardiac Parametric Mapping
NCT02855554
Systemic Lupus Erythematosus in Gullah Health
NCT00756769
Adaptation and Randomized Controlled Trial of Written Exposure Therapy for Adolescents
NCT07498257
Nicotine Replacement Therapy Prescribing and Lung Cancer Screening in Hospitalized Patients
NCT07164404
Post-Operative Steroids After Sleep Surgery
NCT06818981
Out of State - tAN hEDS
NCT06548594
Open Trial of Technology-Enhanced Behavioral Intervention for Buprenorphine Retention in Pregnant and Postpartum People
NCT06496230
rTMS in Older Adults With MCI and AUD
NCT05896332
Feasibility Trial of Preoperative 5-Day Hypofractionated Radiotherapy for Primary Soft Tissue Sarcoma
NCT05776667
Spectral Characteristics of Memory Transformation
NCT05946616
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 104 |
| Phase 2 | 124 |
| Phase 3 | 23 |
| Phase 4 | 43 |
Therapeutic Areas
What is open in the Medical University of South Carolina pipeline
142 recruiting of 755 indexed (19% open); 520 completed (69%).
Phase mix: 66 late (III/IV) vs 228 early (I/II) (early-phase heavy).
Top condition: Stroke (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Medical University of South Carolina: open-pipeline peers nationwide
Peers matched on 755 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
Medical University of South Carolina sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 755 trials (± recruiting share)
- University of California, San Diego · 775 trials · 18% recruiting
- The University of Texas Health Science Center, Houston · 732 trials · 20% recruiting
- Dana-Farber Cancer Institute · 781 trials · 14% recruiting
- University of Miami · 721 trials · 20% recruiting
Sponsors near 19% open enrollment (± trial volume)
- Spaulding Rehabilitation Hospital · 19% recruiting · 101 trials
- Ipsen · 19% recruiting · 85 trials
- EyePoint Pharmaceuticals · 19% recruiting · 16 trials
- Hebrew SeniorLife · 19% recruiting · 32 trials
Related
What to do with this Medical University of South Carolina page
755 registered trials is a research-attention snapshot, not an endorsement of Medical University of South Carolina or any single study.
- 142 of Medical University of South Carolina's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Stroke is the condition Medical University of South Carolina studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Medical University of South Carolina pipeline card: 755 registered trials from official public datasets.Report a data error.